Construction Equipment Market to Reach US$ 230.5 Bn By 2022 – Credence Research

According to a new industry report published by Credence Research Inc “Construction Equipment industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2022,” the construction equipment industry is expected to reach US$ 230.5 Bn by 2022, the industry for construction equipment is expected grow with rising investments in construction sectors supported by improving economic conditions across the world.

In addition, flexible credit policies to purchase construction equipment are also expected to fuel the demand for construction equipment. Growing construction rental sector represents a positive outlook for the construction equipment industry.

Browse Full Report At http://www.credenceresearch.com/report/construction-equipment-industry

Earth moving equipment accounted for the largest revenue share compared to other type of construction equipment in 2014. The earth moving equipment segment includes loaders, excavators, bulldozers and other equipment used for trench digging, foundation building, loading and other earth moving applications. The demand for earth moving equipment is expected to grow with increasing urbanization across the world.

Loader is the most selling earth moving equipment type in terms of volume. Material handling equipment segment is expected to see the fastest growth through the forecast period. Rising investment in energy sector and construction of bridges to improve transportation network is expected to fuel the demand for material handling equipment.

Asia Pacific is the largest regional industry for construction equipment and accounted for more than half revenue share in the global construction equipment industry. Rising investment in construction sector in India and China to support their economic developments is the primary factor expected to influence the demand for construction equipment. In North America and Europe demand for construction equipment is expected to increase steadily with replacement of old equipment with advanced equipment. China is the largest individual industry for construction followed by the U.S. The significant demand for construction equipment is also expected from emerging economies such as Brazil, South Africa and Russia.

The global construction equipment industry is dominated by Caterpillar. Some other recognized players in this industry include Komatsu (Japan), Hitachi (Japan), Volvo (Sweden), Liebherr (Switzerland), Zoomlion (China), Sany (China), Doosan (South Korea), Terex (U.S.), and John Deere (U.S.). Global manufacturers are facing challenge from low cost Chinese manufacturers particularly in emerging and price sensitive industrys.

Request Free Sample: http://www.credenceresearch.com/sample-request/57745

Latest Reports:

Geomembrane industry Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Flooring industry Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2020

Air Handling Units industry By Product (Packaged, Modular, Custom), Capacity (Less than 5000m3/hr, 5000m3/hr to 15000m3/hr, higher than 15000m3/hr), Application (Commercial, Residential) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Photonic Integrated Circuits (PIC) Market: Global Industry Analysis, Market share and Forecast 2022

According to a new industry report published by Credence Research Inc., “Photonic IC industry (Optical Communications (Wireless Access Networks, Long Haul and Transport Networks, Data Centers, etc.), Sensing (Engineering, Energy and Utilities, Transport and Aerospace, etc.), Biophotonics (Medical Devices, Photonic Lab-On-A-Chip, etc.), and Optical Signal Processing (Quantum Optics, Quantum Computing, Optical Metrology, etc.)) – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2022”, the photonic integrated circuits (PIC) industry is expected to witness strong growth during the forecast period, driven primarily by the growing demand from telecom networks and data center applications.

Photonic integrated circuits use photons for transmitting data. Photons traveling at the speed of light enable photonic ICs to transfer data at comparatively greater speed than electronic ICs. Thus, photonic integrated circuits are increasingly integrated within optical communication systems to transfer large amount of data at high speed and over a longer distance. With the advancements in technology, the next generation applications in communication, storage, and computing are expected to possess increased level of bandwidth requirement as compared to today’s existing bandwidth needs. Integrating photonic integrated circuits with programmable electronics into a single discrete package reduce power consumption, system cost, and improve data transfer rate, reliability, and energy efficiency, without compromising on the level of performance. As such, photonics is poised to become the enabling technology for all future wired broadband and wireless technologies.

Browse the full Photonic IC (Optical Communications industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast report at http://www.credenceresearch.com/report/photonic-integrated-circuits-market

Proliferation of the Internet resulting in increased number of users and need for greater bandwidth and transmission speed has necessitated the need for network infrastructure capable of supporting gigabit transmission speeds. The growing demand for high speed communication is driving the photonic integrated circuits industry. Other established application fields of photonic integrated circuits include sensing and biophotonics. Features such as electromagnetic immunity, high sensitivity, low cost of integration, and metal free operation have extended sensing applications of photonic ICs to different verticals including aerospace, transport, energy, utilities, and structural engineering among others. These features enable photonic sensors to measure or detect parameters accurately. On the other hand, the introduction of photonics into life science ecosystem has developed fast, accurate and reliable treatment techniques. With the advancements in healthcare technologies, biophotonics is expected to remain the focal point of the photonic IC industry during the forecast period 2015 – 2022.

Latest Reports:

Electric Motors industry By Type (AC & DC Motors), Output Capacity (Low, Medium, High Voltage Motors), Application (Automobile, HVAC Equipment, Industrial Application, Aerospace and Defense, Utilities, Commercial Sectors), Energy Efficiency Class (IE1, IE2, IE3, Below IE1 Class Motors) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Global Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022

The latest industry report published by Credence Research “Global Breast Biopsy Devices industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the breast biopsy devices industry was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.

Industry Insights

Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing industrys, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices industry has witnessed phenomenal growth over the period.

Browse the full report Breast Biopsy Devices industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/breast-biopsy-devices-market

Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices industry. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major industry drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the industry development and assisted in containment of breast cancer incidence.

Industry Competition Assessment

The global breast biopsy devices industry is consolidated with a few players dominating the major chunk of the industry revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global industry leaders. Other players such as Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising industry players with their established positions in prime industry segments.

Key industry Movements

Increased preference for minimally invasive biopsies
Rapid shift towards guided biopsies
Growth in adoption of disposable consumables

Blog: 

Request Free Sample: http://www.credenceresearch.com/sample-request/57742

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Electrical Conduits Industry is estimated to expand with a CAGR of 9.2% from 2015 to 2022.

According to a new industry research report published by Credence Research “Electrical Conduit Systems (Rigid & Flexible; Metallic & Non-metallic) industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2022” the global electrical conduits industry was valued at US$ 3,954.1 Mn in 2014 and is estimated to expand with a CAGR of 9.2% from 2015 to 2022.

Industry Insights

Electrical conduit systems form a subset of cable management systems which are used for carrying cables and wires. Conduits are tubular raceways designed for protection and routing of electrical cables/wires. The electrical conduit system comprises tubing (conduit) and the required fitting components such as elbows, clamps, connectors and others. The most popular types of electrical conduits include galvanized steel rigid conduits (GRC), electrical metallic tubing (EMT), intermediate metal conduit (IMC), aluminum rigid conduit and PVC conduit. By far, GRCs account for the largest share, in terms of revenue, in the global industry. However, in terms of penetration, PVC conduit systems account for the largest share worldwide.

Browse the full report at (Electrical Conduit Systems industry – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2021) http://www.credenceresearch.com/report/electrical-conduit-systems-market

The electrical conduit systems industry is largely driven by the ever-rising construction industry worldwide. Due to growing construction activities across the industrial, commercial and residential sectors, the demand for electrical conduit systems is expected to remain consistent in the coming years. Further, superior advantages over other wiring methods is another major factor propelling the industry growth. Nevertheless, the industry faces significant challenges due to higher costs of conduit systems coupled with availability of alternatives.

Browse the full report at (Electrical Conduit Systems industry – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2021) http://www.credenceresearch.com/report/electrical-conduit-systems-market

Competitive Insights

The overall electrical conduit systems industry is fragmented in nature with large number of players operating in the industry globally. However, the industry scenario varies largely across each of the major geographies. For instance, the industry in Asia Pacific is more fragmented and unorganized as compared to that in North America and Europe. This is due to large number of regional players in the region making higher industry penetration difficult for any single player. On the contrary, North America industry is quite consolidated with some of the major players such as Atkore International, Inc., Thomas and Betts Corporation, Robroy Industries, Inc. and others accounting for substantial industry share.

Sample: http://www.credenceresearch.com/sample-request/57741

Key Trends

Penetration in emerging economies having booming construction industry
Focus on providing halogen free and green conduit systems suitable for food and healthcare applications
Emphasis on providing conduit systems to the industrial segment due to its high profitability
Focus on online sales due to growing online retail industry
About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Laxatives Market: Global Industry Analysis, Market share and Forecasts 2022

The latest industry report published by Credence Research, Inc. “Global Laxatives industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the laxatives industry was valued at USD 4,495.70 Mn in 2015, and is expected to reach USD 6,948.07 Mn by 2022, expanding at a CAGR of 5.6% from 2016 to 2022; where OTC drugs occupy the largest industry share.

Browse the full report Global Laxatives industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 report at http://www.credenceresearch.com/report/laxatives-market

Industry Insights
Constipation is one of the most common conditions diagnosed in clinical practice, with up to one-fifth of the general population suffering from chronic constipation. Certain studies have reported 24% to 50% prevalence in older adults. It is also observed that between 10% and 18% geriatrics in community dwellings and 74% residents in nursing homes regularly use laxatives. Constipation can have significant impact on everyday functions and quality of life of patients. Severe cases of constipation may also lead to coronary episodes, cerebral ischemia and syncope. In order to mitigate the complications arising from uncontrolled or un-

Fumaric Acid Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2021

According to a new industry report published by Credence Research “Fumaric Acid industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2021,” the fumaric acid industry was valued at US$ 3.70 Bn in 2015, and is expected to reach US$ 5.69 Bn by 2022, expanding at a CAGR of 6.3% from 2016 to 2022.

Industry Insights
Fumaric acid which is also known as trans-butenedioic acid is witnessed to experience high demand from various applications in the global industry. The benefits such as increasing the shelf life of food and flavor enhancement among others are the major factor for high demand from the food and beverages industry. The growing demand for unsaturated polyesters resins from the automobile industry is another factor promoting the growth of global fumaric acid industry.

Growing health awareness among the population has led to adoption of nutritional diets. This has increased the demand for processed foods and drinks. Therefore, high demand for fumaric acid is observed, as it is used as preservative for processed foods and drinks. Rise in use of automobiles in emerging economies is expected to increase automobile industry in Thailand and Indonesia. Rising economic conditions in the countries such as China and India has led to high demand for unsaturated polyester resins thereby leading to growth of fumaric acid in the industry. The benefits such as flavor stability, persistent sour taste, and greater buffering capacity among other benefits are expected to offer high opportunities for industrial applications in the industry.

Browse the full Fumaric Acid industry for Food & Beverages, Unsaturated Polyester Resins (UPR), Alkyd Resins, Printing Inks, Paper Sizing and Other Applications- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2021 report at http://www.credenceresearch.com/report/fumaric-acid-market

Competitive Insights:
Food & Beverages was leading the application segment with more than 25% share of global fumaric acid industry. The beneficial properties of fumaric acid such as flavor enhancer, preservative and pH controller are expected to boost industry demand from the food 7 beverages industry. Fumaric acid is used in the production of bakery, breads, confectionary, desserts, etc. Hence, high demand for fumaric acid is reported from the food industry. Unsaturated polyester resins accounted to be the second largest application segment in 2015 and is expected to retain its industry position during the forecast period. High demand for unsaturated polyester resins from the automobile and marine industries has led to increased production and demand for fumaric acid. Other application such as alkyd resins, printing inks, paper sizing, animal feed and cleansing agents are also projected to offer high opportunities for growth of fumaric acid industry during the forecast period from 2016 to 2022.

Sample: http://www.credenceresearch.com/sample-request/57739

Major players involved in the production and sales of fumaric acid are focusing on synthesis of fumaric acid through fermentation processes globally. To increase industry opportunities, the major weapon used by small as well as major players is backward and forward integration. In-house synthesis of fumaric acid will help reduce cost of raw material and will add to the product portfolio of the company. Hence, strong competition is observed between the prominent and major players in the industry.

Key Trends:

Manufacture of various food products
Potential substitute to tartaric acid and citric acid
Developments in the automobile sector
Opportunities for growth in construction and paints & coatings industry

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Global Chronic Idiopathic Constipation (CIC) Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022

The latest industry report published by Credence Research, Inc. “Global Chronic Idiopathic Constipation (CIC) Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the chronic idiopathic constipation drugs industry was valued at USD 1675.4 Mn in 2015, and is expected to reach USD 2570.8 Mn by 2022, expanding at a CAGR of 6.4% from 2016 to 2022.

Browse the full report Chronic Idiopathic Constipation (CIC) Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 report at http://www.credenceresearch.com/report/chronic-idiopathic-constipation-cic-drugs-market

Industry Insights

Growing awareness and increasing incidence and prevalence of chronic idiopathic constipation – CIC are the major factors driving the CIC drugs industry worldwide. Growth in demand for CIC drugs in Asia Pacific, coupled with the huge gap of unmet needs in the region is expected to serve as a significant opportunity in the global industry during forecast period.chronic-idiopathic-constipation-cic-industry-by-drug-type

In terms of geographical distribution, North America captures over 40% share of the global industry revenue. US is the largest national industry for CIC drugs due to greater prevalence of lifestyle respective diseases, higher incidence of constipation, higher healthcare spending and rather greater adoption of pharmaceuticals for treating ailments. As per the National Institutes of Health (NIH) CIC affects approximately 63 Mn individuals in the US. On the other hand, growing awareness in the rapidly developing Asian countries such as China and India will create significant growth opportunities in the Asia Pacific industry.

In terms of industry segmentation by drug type, Lubiprostone drugs segment currently dominates the industry. However, the segment due to its relatively lower efficacy, patent loss and growing competition from Linaclotide will lose its dominance in the upcoming future. The Linaclotide drugs industry for CIC treatment is anticipated to grow at a CAGR of 7.7% during 2016 – 2022.

Request Sample: http://www.credenceresearch.com/sample-request/57738

Analyzing the symptoms, constipation is not considered as a disease but a condition, side effect or syndrome. This factor greatly contributes to the lesser visits from patients to address the issue. Thus over 65% of the CIC drugs industry is captured by OTC drugs segment. The OTC industry is expected to continue to dominate the industry at a CAGR of 6.6% during 2016 – 2022.

The CIC drugs industry is currently open for further research and development and thus introduction of novel pharmaceutical solutions. Actavis, Chugai Pharmaceutical, Ferrin International, Synergy Pharmaceuticals and others are among the top payers active in the global chronic idiopathic constipation drugs industry.

Blog: http://prnewswireindustry.blogspot.com/2016/11/chronic-idiopathic-constipation-drugs.html

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Chronic Idiopathic Constipation Drugs Market is expected to reach USD 2570.8 Mn by 2022, expanding at a CAGR of 6.4% from 2016 to 2022.

The latest industry report published by Credence Research, Inc. “Global Chronic Idiopathic Constipation (CIC) Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the chronic idiopathic constipation drugs industry was valued at USD 1675.4 Mn in 2015, and is expected to reach USD 2570.8 Mn by 2022, expanding at a CAGR of 6.4% from 2016 to 2022.

Browse the full report Chronic Idiopathic Constipation (CIC) Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 report at http://www.credenceresearch.com/report/chronic-idiopathic-constipation-cic-drugs-market

Industry Insights

Growing awareness and increasing incidence and prevalence of chronic idiopathic constipation – CIC are the major factors driving the CIC drugs industry worldwide. Growth in demand for CIC drugs in Asia Pacific, coupled with the huge gap of unmet needs in the region is expected to serve as a significant opportunity in the global industry during forecast period.chronic-idiopathic-constipation-cic-industry-by-drug-type

In terms of geographical distribution, North America captures over 40% share of the global industry revenue. US is the largest national industry for CIC drugs due to greater prevalence of lifestyle respective diseases, higher incidence of constipation, higher healthcare spending and rather greater adoption of pharmaceuticals for treating ailments. As per the National Institutes of Health (NIH) CIC affects approximately 63 Mn individuals in the US. On the other hand, growing awareness in the rapidly developing Asian countries such as China and India will create significant growth opportunities in the Asia Pacific industry.

In terms of industry segmentation by drug type, Lubiprostone drugs segment currently dominates the industry. However, the segment due to its relatively lower efficacy, patent loss and growing competition from Linaclotide will lose its dominance in the upcoming future. The Linaclotide drugs industry for CIC treatment is anticipated to grow at a CAGR of 7.7% during 2016 – 2022.

Request Sample: http://www.credenceresearch.com/sample-request/57738

Analyzing the symptoms, constipation is not considered as a disease but a condition, side effect or syndrome. This factor greatly contributes to the lesser visits from patients to address the issue. Thus over 65% of the CIC drugs industry is captured by OTC drugs segment. The OTC industry is expected to continue to dominate the industry at a CAGR of 6.6% during 2016 – 2022.

The CIC drugs industry is currently open for further research and development and thus introduction of novel pharmaceutical solutions. Actavis, Chugai Pharmaceutical, Ferrin International, Synergy Pharmaceuticals and others are among the top payers active in the global chronic idiopathic constipation drugs industry.

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Opioid Induced Constipation Drugs market is expanding at a CAGR of 4.6% from 2016 to 2022

The latest industry report published by Credence Research “Global Opioid Induced Constipation Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the opioid induced constipation drugs industry was valued at USD 1,933.2 Mn in 2015, and is expected to reach USD 2,779.24 Mn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022; where North America is has the largest industry share.

Browse the full report Opioid Induced Constipation Drugs industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 report at http://www.credenceresearch.com/report/opioid-induced-constipation-oic-drugs-market

Industry Insights

Opioids affect the gastrointestinal tract by increasing the required time for moving stool from the gastric system. Opioids also partially paralyze the digestive system thus leaving food remains in the GI tract for a longer time period. They also reduce digestive secretions and the urge to defecate. According to this report, North America is the largest OIC drugs industry and is valued at USD 794.5 Mn in 2015.OIC Drugs industry

North America has two of the most developed nations in the world with advanced and well organized healthcare infrastructures: U.S. and Canada. The overall drugs industry is the largest in the U.S. The OIC drugs industry in the North America is expected to maintain a steady growth and exhibit further potential with the commercialization of current pipeline drugs. Moreover, greater potential due to government initiatives to further improve healthcare services in the society by providing latest technical and pharmacological treatments support the domination of North America industry. Growing lifestyle related diseases, increased healthcare spending mad technological advancement in pain management are the other prime factors responsible for the growth of this industry.

Europe on the other hand, exhibits mixed industrys for healthcare sector. The region constantly adopts the latest healthcare systems to provide the best possible healthcare assistance for patients. The healthcare spending of European countries is increasing considerably. According to W.H.O. estimations, in 2013, the EU spent USD 3,520 per person in healthcare. Constipation is very common in Europe and the region has the largest share in drug industry for OIC treatment.

On the other hand, Asia Pacific is the fastest growing regional industry for OIC drugs. Rapid evolution of healthcare infrastructure across the region, coupled with the rising incidence of OIC is the major responsible factors for the growth of OIC drugs in the region. China has the largest industry share for the drugs manufacturers in this region as this is one of the most potential industrys for pharmaceutical giants. The Drugs used for treatment of these disorders in APAC regions are the global brands and pharmaceutical companies who are ruling the constipation drug industry. Some of the common drugs are AMITIZA, LINZEES and various others like Ironwood also has partnered linaclotide with Astellas Pharma Inc. for development and commercialization in Japan and certain other Asian countries and with AstraZeneca for development and commercialization in China.

Request Free Sample: http://www.credenceresearch.com/sample-request/57737

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Irritable Bowel Syndrome with diarrhea (IBS-D) drugs industry is expanding at a CAGR of 13.89% from 2016 to 2022.

As stated in a recently published information by Credence Research, Inc. “Global Irritable Bowel Syndrome with Diarrhea (IBS-D) industry - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the irritable bowel syndrome with diarrhea (IBS-D) drugs industry was valued at USD 289.3 Mn in 2015, and is expected to reach USD 1,115.06 Mn by 2022, expanding at a CAGR of 13.89% from 2016 to 2022.

Industry Insights

Recent approvals for two new prescription drugs to treat irritable bowel syndrome with diarrhea (IBS-D) have become the biggest phenomenon in the IBS-D drugs industry. These approvals are viewed as breakthrough step in the long struggle to discover effective treatment for IBS-D.

Viberzi (eluxadoline) assists in controlling bowel contractions thus containing diarrhea, whereas Xifaxan (rifaximin) is an antibiotic that treats diarrhea by altering the gut flora. Xifaxan had been used off label for treating IBS-D, thus direct approval for treating IBS-D will lead to growth in demand for Xifaxan during the forecast period. Drugs such as loperamide will experience a slack in demand due to the introduction of the said novel drugs.

Browse the full report Irritable Bowel Syndrome with Diarrhea (IBS-D) industry at http://www.credenceresearch.com/report/irritable-bowel-syndrome-ibs-with-Diarrhea-drugs-market

Geographically, North America is the largest industry for IBS-D drugs. Higher awareness about the disease, expected prompt availability of the newly approved drugs, better reimbursement system and higher IBS prevalence are the prime factors that drive the IBS-D drugs industry in North America. On the other hand, Asia Pacific is expected to be the fastest growing regional industry for IBS-D drugs. It is estimated that Asia Pacific industry will progress at a CAGR of approximately 17% during the forecast period 2016-2022. Japan with its largest pool of geriatric population and with the anticipated approval for Xifaxan in 2018 makes the country the largest national industry in Asia Pacific region. In addition, it is also estimated that due to factors such as moderate purchasing power in the patient population, lower diagnosis rates and poor disease awareness will contribute to sustained demand for OTC IBS-D drugs in the region. Regions such as Latin America and MENA are believed to follow the trends in Europe and North America industry.

Request Free Sample : http://www.credenceresearch.com/sample-request/57736

Commenting on the competitive scenario, the IBS-D drugs industry is fragmented with no clear leader in terms of industry revenue share. However, it is expected that with gradual approvals in the international industrys, Valeant (Salix Pharmaceuticals) will emerge the industry leader in the overall IBS drugs industry with products for both IBS-D and IBS-C treatment.

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Agriculture Market Assessment Report Now Available at Credence Research

Credence Research has recently issued a new indusry assessment report titled “Agriculture – Growth, Future Prospects and Competitive Analysis, 2016 – 2022”. The global Agriculture indusry study provides a comprehensive view of the ongoing and future phases of the Agriculture industry based on parameters such as major commercial events, research initiatives, government guidelines, indusry drivers, restraints and opportunities and detailed industry segmentation and regional distribution.

Browse the report at: http://www.credenceresearch.com/report/agriculture-market

Based on geographic/regional distribution the global Agriculture indusry is studied for key regional indusrys focusing on the respective geographic trends and statistics, and thereby delivering indusry size and forecast values. The Agriculture indusry based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa indusrys. Among these, the North America, Europe and Asia-Pacific Agriculture indusry is studied for top country-level indusrys. The Agriculture industry in each individual country indusry is studied based on parameters such as per capita income, population, gross domestic product (GDP), status of infrastructure, purchasing power parity, etc. Technology development, industry concentration, end-user preference, and similar such grounds are also considered while estimating the indusry for Agriculture. The indusry estimates are provided for the period 2014-2022, along with corresponding compounded annual growth rates (CAGRs) for the forecast period 2016-2022.

Request Table of content - http://www.credenceresearch.com/request-table-of-content/57730

This report on Agriculture indusry also offers competition assessment tools such as indusry positioning of key players, attractive investment proposition, and Porter’s Five Forces model to give the readers a view of the competitive scenario of the Agriculture indusry. The Agriculture indusry report is concluded with company profiles chapter. This section highlights major information about the key players engaged in development, manufacture, distribution and sale of Agriculture in the international indusrys.

Request free sample - http://www.credenceresearch.com/sample-request/57730

Major extracts from the Table of Content of Agriculture indusry, 2016-2022 report:
Agriculture indusry Dynamics – Drivers, Challenges, Opportunities
Agriculture indusry Size and Forecast for the Period 2014-2022
Agriculture indusry CAGR for the Period 2016-2022
Agriculture indusry Competitive Analysis, by Key Players
Agriculture indusry: Attractive Investment Proposition, by Geography
Agriculture indusry: Key Commercial Events
Agriculture indusry: Future Prospects (upcoming product approvals)
Company Profiles

Latest Reports:

·         Global Automated Microbiology Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

·         Global Biomarkers Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

·         Global Cell Culture Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

About Us:
Credence Research is a worldwide indusry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290